Structure-based virtual screening, molecular docking, and MD simulation studies: An in-silico approach for identifying potential MBL inhibitors.

PLoS One · 2025 · PMC12312920 · PMID 40743310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

(Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: SECTION 1: PLOS ONE REVIEWER GUIDELINES • What are the main claims of the paper and how significant are they for the discipline? I think they are moderately significant. • Are the claims properly placed in the context of the previous literature?

also in 2,178 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.